Home · Open Lab · Lot RGX-26-GLP-692
RGX-26-GLP-692Superseded
GLP-1-SM · 15 MG · Metabolic Research · COA NS-2026-05092

Release test results

99.750%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 15.04 mg
Related impurities (total)0.250%
Endotoxin<1.0 EU/mg
HPLC retention time4.76 min
MethodHPLC + LC-MS
ResultPass · meets spec

Lot record

CompoundGLP-1-SM
Presentation15 MG
Lot numberRGX-26-GLP-692
COA numberNS-2026-05092
Test date05 Sep 2026
Release date08 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

GLP-1-SM — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-GLP-69310 MGSep 8, 202699.674%Superseded
RGX-26-GLP-69120 MGSep 7, 202699.743%Superseded
RGX-26-GLP-100920 MGSep 6, 202699.723%Current
RGX-26-GLP-79215 MGSep 6, 202699.636%Superseded
RGX-26-GLP-100815 MGSep 5, 202699.580%Current
RGX-26-GLP-692 this lot15 MGSep 5, 202699.750%Superseded
RGX-26-GLP-79030 MGSep 5, 202699.705%Superseded
RGX-26-GLP-101030 MGSep 4, 202699.685%Current
RGX-26-GLP-79310 MGSep 4, 202699.697%Superseded
RGX-26-GLP-69030 MGSep 4, 202699.598%Superseded
RGX-26-GLP-100710 MGSep 3, 202699.763%Current
RGX-26-GLP-79120 MGSep 3, 202699.712%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →